BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1172903)

  • 1. Ovulation inhibition with human chorionic gonadotrophin.
    Friedrich F; Kemeter P; Salzer H; Breitenecker G
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):332-42. PubMed ID: 1172903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
    Fogel M; Rubin BL; Ossowski R
    Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
    J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of exogenous human chorionic gonadotrophin on progesterone production from normal or malfunctioning corpus luteum.
    Momoeda M; Tsutsumi O; Morita Y; Igarashi T; Suenaga A; Osuga Y; Shiotsu H; Yano T; Taketani Y
    Hum Reprod; 1998 Jul; 13(7):1907-11. PubMed ID: 9740447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary and ovarian hormone secretion and ovulation in gilts injected with gonadotropins during and after oral administration of progesterone agonist (Altrenogest).
    Guthrie HD; Bolt DJ
    Biol Reprod; 1985 Oct; 33(3):679-89. PubMed ID: 3931712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
    Weissman A; Loumaye E; Shoham Z
    Hum Reprod; 1996 May; 11(5):943-9. PubMed ID: 8671368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LH, FSH and ovarian steroids in serum during normal menstrual cycles and cycles with corpus luteum insufficiency in the human female (author's transl)].
    Leyendecker G; Hinckers K; Nocke W; Plotz EJ
    Arch Gynakol; 1975; 218(1):47-64. PubMed ID: 1173547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.
    Romeu A; Monzó A; Peiró T; Diez E; Peinado JA; Quintero LA
    J Assist Reprod Genet; 1997 Oct; 14(9):518-24. PubMed ID: 9401870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ovulatory cycle. A histologic, thermal, steroid, and gonadotropin correlation.
    Lundy LE; Lee SG; Levy W; Woodruff JD; Wu CH; Abdalla M
    Obstet Gynecol; 1974 Jul; 44(1):14-25. PubMed ID: 4834794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blockade of LH and FSH peaks by low doses of exogenous progesterone in the human female (author's transl)].
    Netter A; Gorins A; Thomas K; Cohen M; Joubinaux J
    Ann Endocrinol (Paris); 1973; 34(4):430-5. PubMed ID: 4779738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of prolactin in the restoration of ovarian function during the early post-partum period in the human female. II. A study during inhibition of lactation by bromergocryptine.
    Rolland R; de Jong FH; Schellekens LA; Lequin RM
    Clin Endocrinol (Oxf); 1975 Jan; 4(1):27-38. PubMed ID: 1122652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.